Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome
Summary
Clopidogrel, together with a low dose of aspirin, should be used for people with non-ST-segment-elevation acute coronary syndrome who have a moderate to high risk of a major heart attack (myocardial infarction) or death. Whether a person is at moderate to high risk of a major heart attack can be jud ...
Read the complete summary
Clopidogrel, together with a low dose of aspirin, should be used for people with non-ST-segment-elevation acute coronary syndrome who have a moderate to high risk of a major heart attack (myocardial infarction) or death. Whether a person is at moderate to high risk of a major heart attack can be judged from their symptoms and by one or both of the following test results.
- New ECG changes that show that the person’s heart is not receiving enough blood. (An ECG,or heart trace, is a test that shows how the heart is beating. Doctors can tell from the pattern on the ECG if there are problems.)
- Blood tests that show that there has been some damage to the heart tissue.
Treatment with clopidogrel and low-dose aspirin should be continued for up to 12 months after the most recent attack. After this time, doctors should give the normal treatment, which includes a low dose of aspirin.
hide
Guidance documents
Implementing this guidance
Other information
